John W. Suttie

The Scientist Date: September 16, 1996 THE SCIENTIST® The Newspaper for the Life Sciences Professional "THE SCIENTIST provides a good overview of topics of interest to the scientific community. It provides useful information on public policy issues and advances in the biological sciences." John W. Suttie, Professor and Chairman.Department of Nutritional Sciences and Professor Department of Biochemistry, University of Wisconsin, Madison John W. Suttie, professor and chairman, department

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: September 16, 1996

John W. Suttie, Professor and Chairman.
Department of Nutritional Sciences and Professor
Department of Biochemistry, University of Wisconsin, Madison

To help the scientific community reach this goal, Suttie is involved in a number of scientific organizations and currently serves as president of the Federation of American Societies for Experimental Biology (FASEB). This group represents 10 societies and 44,000 individual biomedical research scientists.

His research involves studies of the mechanism of action of vitamin K as an enzymatic cofactor and investigations into the metabolism of and the nutritional role of this vitamin. He was elected to membership in the National Academy of Sciences in 1996.

As a reader of THE SCIENTIST, Suttie says: "THE SCIENTIST provides a good overview of topics of interest to the scientific community. It provides useful information on public policy issues and advances in the biological sciences."

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies